在儿科急性淋巴细胞白血病的新型治疗方法
Maria Maddalena Marrapodi1, Alessandra Di Paola1,2, Giuseppe Di Feo1
1Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", 80138 Napoli, Italy.
儿童急性淋巴细胞白血病 (ALL) 治疗正在通过向疗法和免疫疗法取得进展. 这些新的方法旨在改善ALL儿童的生存率和降低毒性.
科学领域:
- 儿科血液学/瘤学
- 癌症免疫疗法癌症免疫疗法
- 精准医学是一门精准的医学.
背景情况:
- 急性淋巴细胞白血病 (ALL) 是最常见的儿童癌症,由淋巴细胞前体引起.
- 传统的化疗改善了生存率,但导致了显著的毒性,需要精细的治疗策略.
- 亚型 (B细胞ALL与T细胞ALL) 由于影响治疗和预后的不同特征至关重要.
研究的目的:
- 提供对儿科ALL病理生物学和当前治疗方法的全面审查.
- 强调免疫治疗策略在治疗儿科ALL中日益重要.
- 突出针对性和基于免疫的疗法的整合,以改善结果和降低毒性.
主要方法:
- 对分子分析数据的审查,以确定ALL的关键瘤性途径.
- 对向疗法的临床数据分析,包括氨酸激酶抑制剂 (TKI) 和表观遗传调节剂.
- 评估免疫治疗剂,如双特异性抗体,抗体与药物合物,单克隆抗体和CAR-T细胞疗法.
主要成果:
- 向疗法 (TKIs,JAK-STAT抑制剂,BCL-2抗剂) 提供了更有选择性的治疗选择.
- 免疫疗法 (blinatumomab,inotuzumab,ozogamicin,daratumumab,CAR-T细胞疗法) 显示出显著的疗效,特别是在复发性/耐药的儿科ALL.
- 与传统化疗相比,这些新药显示出更好的安全性.
结论:
- 将向性和免疫疗法整合到传统疗法中,标志着在儿科ALL中向精准医学的转变.
- 这些先进的策略旨在提高生存率,同时尽量减少短期和长期治疗相关的毒性.
- 不断发展的治疗环境有望为被诊断为ALL的儿童改善生活质量.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
